Toxicity of 5-bromo-2'-deoxyuridine to malignant lymphoid cell lines.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008214:Lymphocytes / Q000187:drug effects; D008223:Lymphoma / Q000188:drug therapy*; D009101:Multiple Myeloma / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013936:Thymidine / Q000494:pharmacology
D000970:Antineoplastic Agents; D001973:Bromodeoxyuridine; D013936:Thymidine